Cite this page: Bychkov A. Staging. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/lungtumorstaging.html. Accessed December 25th, 2024.
Pathologic TNM staging of carcinomas of the lung, AJCC 8th edition
Definition / general
Applicable to carcinomas of the lung, including non small cell and small cell carcinomas and bronchopulmonary carcinoid tumors, does not apply to sarcomas or other rare tumors of the lung
WHO has defined new entities of adenocarcinoma in situ and minimally invasive adenocarcinoma, which are assigned to Tis and T1mi categories, respectively
Essential features
T, N and M categories code the anatomic extent of lung cancer and predict overall survival of patients with non small cell and small cell carcinomas
The 8th edition AJCC / TNM classification has provided a more comprehensive stratification of tumors based on subdivision of T, N and M categories and also adopted the newly introduced histological entities of lung carcinoma
pTX: primary tumor cannot be assessed or tumor proven by the presence of malignant cells in sputum or bronchial washings but not visualized by imaging or bronchoscopy
pT0: no evidence of primary tumor
pTis: carcinoma in situ, squamous cell carcinoma in situ, adenocarcinoma in situ (pure lepidic pattern and ≤ 3 cm)
pT1mi: minimally invasive adenocarcinoma (≤ 3 cm with a predominantly lepidic pattern and ≤ 5 mm of invasion)
pT1a: tumor ≤ 1 cm or rarely a superficial, spreading tumor of any size with invasive component limited to the bronchial wall that may extend proximal to the main bronchus
pT1b: tumor > 1 cm but ≤ 2 cm
pT1c: tumor > 2 cm but ≤ 3 cm
pT2: tumor > 3 cm but ≤ 5 cm or involves the main bronchus regardless of distance to the carina without involvement of the carina, invades visceral pleura (PL1 or PL2) or is associated with atelectasis or obstructive pneumonitis that extends to the hilar region involving part or all of the lung
pT2a: tumor > 3 cm but ≤ 4 cm or has 1 of the above features and size cannot be determined
pT2b: tumor > 4 cm but ≤ 5 cm
pT3: tumor > 5 cm but ≤ 7 cm or directly invades parietal pleura (PL3), chest wall (including superior sulcus tumors), phrenic nerve or parietal pericardium or presence of a separate tumor nodule in the same lobe
pT4: tumor > 7 cm or tumor of any size invading diaphragm, mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body or carina or presence of a separate tumor nodule in an ipsilateral different lobe
Notes:
Tumor size has important prognostic relevance; each centimeter increase in size, from less than 1 cm to up to 5 cm, yields a significantly different prognosis
Multiple tumors with predominant ground glass features on CT and a lepidic pattern on pathological examination
Diffuse pneumonic type lung cancer
Multiple primary tumors
Considered separate primary tumors if different histologic types (e.g., squamous carcinoma and adenocarcinoma) or are squamous carcinomas that have arisen from carcinoma in situ
Different biomarker pattern and absence of nodal or systemic metastases favor multiple primary tumors
Single primary tumor
Considered to have arisen from a single tumor if an exact match by comparative genomic hybridization
Similar histologic appearance, matching biomarker patterns and significant nodal or systemic metastases favor a single primary tumor
Regional lymph node (pN)
pNX: regional lymph nodes cannot be assessed
pN0: no regional lymph nodes metastasis
pN1: metastasis in ipsilateral peribronchial, ipsilateral hilar or intrapulmonary lymph node, including involvement by direct extension
pN2: metastasis in ipsilateral mediastinal or subcarinal lymph node
pN3: metastasis in contralateral mediastinal, contralateral hilar, ipsilateral / contralateral scalene or supraclavicular lymph node
Notes:
In addition to anatomic extent of nodal disease, quantification based on the number of involved lymph node stations has prognostic impact
Distant metastasis (pM)
pM0: no distant metastasis
pM1a: separate tumor nodule in a contralateral lobe, pleural nodules, pericardial nodules, malignant pleural effusion or malignant pericardial effusion
pM1b: single extrathoracic metastasis in a single organ (including a single non regional node)
pM1c: multiple extrathoracic metastases in a single organ or in multiple organs
Notes:
Most pleural and pericardial effusions are a result of the tumor
Rarely, fluids are negative for tumor, non bloody and not an exudate; clinical judgment is required in these cases
Number of distant metastases has more prognostic relevance than organ location
AJCC prognostic stage grouping
Occult carcinoma:
TX
N0
M0
Stage 0:
Tis
N0
M0
Stage IA1:
T1mi
N0
M0
T1a
N0
M0
Stage IA2:
T1b
N0
M0
Stage IA3:
T1c
N0
M0
Stage IB:
T2a
N0
M0
Stage IIA:
T2b
N0
M0
Stage IIB:
T1a - c
N1
M0
T2a - b
N1
M0
T3
N0
M0
Stage IIIA:
T1a - c
N2
M0
T2a - b
N2
M0
T3
N1
M0
T4
N0 - 1
M0
Stage IIIB:
T1a - c
N3
M0
T2a - b
N3
M0
T3 - 4
N2
M0
Stage IIIC:
T3 - 4
N3
M0
Survival data
Overall survival
2 years
5 years
Clinical stage
Pathological stage
Clinical stage
Pathological stage
Stage IA1
97%
97%
92%
90%
Stage IA2
94%
94%
83%
85%
Stage IA3
90%
92%
77%
80%
Stage IB
87%
68%
89%
73%
Stage IIA
79%
82%
60%
65%
Stage IIB
72%
76%
53%
56%
Stage IIIA
55%
65%
36%
41%
Stage IIIB
44%
47%
28%
24%
Stage IIIC
24%
30%
13%
12%
Stage IVA
23%
NA
10%
NA
Stage IVB
10%
NA
0%
NA
Registry data collection variables
For surgically resected non small cell lung cancer
A CT detected a ground glass nodule in the upper lung. Surgical resection revealed a 2 cm adenocarcinoma with pure lepidic pattern and no stromal invasion. What is the pT category?
pT0
pT1a
pT1b
pT1mi
pTis
Board review style answer #1
E. pTis. The pTis category for adenocarcinoma in situ was added in the AJCC / TNM 8th edition staging scheme. By definition, this is a localized, small (≤ 3 cm) adenocarcinoma with growth restricted to neoplastic cells along pre-existing alveolar structures (lepidic growth) and lacking stromal, vascular, alveolar space or pleural invasion. Radiologic equivalent is a pure ground glass nodule on CT. In contrast, minimally invasive adenocarcinoma (pT1mi) is defined as a lepidic predominant adenocarcinoma measuring up to 3 cm with an invasive component measuring up to 0.5 cm.